NHS Sicav – Global Strategy fund update – 03/11/15

Posted on Posted in Uncategorised

With a YTD performance in line with our competitors (mixed funds), we believe that it’s a calculated and acceptable risk to increase a little bit more the equity exposure.

We decided to play the “momentum” essentially with ETF’s on EuroStoxx50 and StoxxEurope600, so that we can move quickly if necessary and monitor the downside risk with stop losses.

On a longer term consideration, we decided also to increase slightly our Emerging Market exposure. The “net” equity exposure of the portfolio is 59% now, near our 60% maximum limi

The following two tabs change content below.
Jacques Bossuyt

Jacques Bossuyt

Member of the Investment Committee
Jacques Bossuyt

Latest posts by Jacques Bossuyt (see all)

Leave a Reply

Your email address will not be published. Required fields are marked *